Letter: distinct hepatitis B virus relapse rates after discontinuing tenofovir and entecavir therapy in chronic hepatitis B patients-author's reply
Aliment Pharmacol Ther
.
2019 Apr;49(8):1106-1107.
doi: 10.1111/apt.15183.
Author
Chien-Hung Chen
1
Affiliation
1
Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
PMID:
30920034
DOI:
10.1111/apt.15183
No abstract available
Publication types
Letter
Comment
MeSH terms
Antiviral Agents*
Guanine / analogs & derivatives
Hepatitis B virus
Hepatitis B, Chronic*
Humans
Recurrence
Tenofovir
Substances
Antiviral Agents
entecavir
Guanine
Tenofovir